These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26612852)

  • 1. Innovative financing for late-stage global health research and development: the Global Health Investment Fund.
    Fitchett JR; Fan Li J; Atun R
    Int Health; 2016 Jan; 8(1):3-4. PubMed ID: 26612852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innovative financing for health: what is truly innovative?
    Atun R; Knaul FM; Akachi Y; Frenk J
    Lancet; 2012 Dec; 380(9858):2044-9. PubMed ID: 23102585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An analysis of GAVI, the Global Fund and World Bank support for human resources for health in developing countries.
    Vujicic M; Weber SE; Nikolic IA; Atun R; Kumar R
    Health Policy Plan; 2012 Dec; 27(8):649-57. PubMed ID: 22333685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stakeholders' opinions and expectations of the Global Fund and their potential economic implications.
    Galárraga O; Bertozzi SM
    AIDS; 2008 Jul; 22 Suppl 1(Suppl 1):S7-S15. PubMed ID: 18664957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The GAVI Financing Task Force: one model of partner collaboration.
    Milstien JB; Kamara L; Lydon P; Mitchell V; Landry S
    Vaccine; 2008 Dec; 26(51):6699-705. PubMed ID: 19306508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innovative financing instruments for global health 2002-15: a systematic analysis.
    Atun R; Silva S; Knaul FM
    Lancet Glob Health; 2017 Jul; 5(7):e720-e726. PubMed ID: 28619230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introducing new vaccines in the poorest countries: what did we learn from the GAVI experience with financial sustainability?
    Lydon P; Levine R; Makinen M; Brenzel L; Mitchell V; Milstien JB; Kamara L; Landry S
    Vaccine; 2008 Dec; 26(51):6706-16. PubMed ID: 18952134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Review Of Innovative International Financing Mechanisms To Address Noncommunicable Diseases.
    Meghani A; Basu S
    Health Aff (Millwood); 2015 Sep; 34(9):1546-53. PubMed ID: 26355057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investing for Impact: The Global Fund Approach to Measurement of AIDS Response.
    Jain S; Zorzi N
    AIDS Behav; 2017 Jul; 21(Suppl 1):91-100. PubMed ID: 27896551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 78 countries: immunization financing in developing and transitional countries.
    Deroeck D; Levin A
    Health Reform Prior Serv; 1999; ():21-4. PubMed ID: 12222166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gavi's Transition Policy: Moving From Development Assistance To Domestic Financing Of Immunization Programs.
    Kallenberg J; Mok W; Newman R; Nguyen A; Ryckman T; Saxenian H; Wilson P
    Health Aff (Millwood); 2016 Feb; 35(2):250-8. PubMed ID: 26858377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Financing of global health: tracking development assistance for health from 1990 to 2007.
    Ravishankar N; Gubbins P; Cooley RJ; Leach-Kemon K; Michaud CM; Jamison DT; Murray CJ
    Lancet; 2009 Jun; 373(9681):2113-24. PubMed ID: 19541038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons learned in shaping vaccine markets in low-income countries: a review of the vaccine market segment supported by the GAVI Alliance.
    Gilchrist SA; Nanni A
    Health Policy Plan; 2013 Dec; 28(8):838-46. PubMed ID: 23174880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustainability of National Immunization Programme (NIP) performance and financing following Global Alliance for Vaccines and Immunization (GAVI) support to the Democratic Republic of the Congo (DRC).
    Le Gargasson JB; Breugelmans JG; Mibulumukini B; Da Silva A; Colombini A
    Vaccine; 2013 Apr; 31(15):1886-91. PubMed ID: 23462529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An alternative mechanism for international health aid: evaluating a Global Social Protection Fund.
    Basu S; Stuckler D; McKee M
    Health Policy Plan; 2014 Jan; 29(1):127-36. PubMed ID: 23335466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applying lessons learned from the USAID family planning graduation experience to the GAVI graduation process.
    Shen AK; Farrell MM; Vandenbroucke MF; Fox E; Pablos-Mendez A
    Health Policy Plan; 2015 Jul; 30(6):687-95. PubMed ID: 24974106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health technology assessments as a mechanism for increased value for money: recommendations to the Global Fund.
    Teerawattananon Y; McQueston K; Glassman A; Yothasamut J; Myint CY
    Global Health; 2013 Aug; 9():35. PubMed ID: 23965222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Global Fund to fight HIV/AIDS, TB and malaria policy issues].
    Kerouedan D
    Med Trop (Mars); 2010 Feb; 70(1):19-27. PubMed ID: 20337110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Who pays for cooperation in global health? A comparative analysis of WHO, the World Bank, the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria, and Gavi, the Vaccine Alliance.
    Clinton C; Sridhar D
    Lancet; 2017 Jul; 390(10091):324-332. PubMed ID: 28139255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Country Ownership And Gavi Transition: Comprehensive Approaches To Supporting New Vaccine Introduction.
    Shen AK; Weiss JM; Andrus JK; Pecenka C; Atherly D; Taylor K; McQuestion M
    Health Aff (Millwood); 2016 Feb; 35(2):272-6. PubMed ID: 26858380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.